Case report: A patient with ALK-positive large B-cell lymphoma benefited from myeloma-like treatment combined with the ALK inhibitor lorlatinib - Liu, Dan; Xing, Lijie; Wang, Hui; Li, Ping; Wei, Haichen (Frontiers in Hematology, 2024)